Cargando…

Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth

Liver cirrhosis is a common chronic disease in China. The effect of modified Xianglian Pingwei powder plus Western medicine in the treatment of liver cirrhosis and positive small intestinal bacterial overgrowth is promising. Totally, 100 patients with liver cirrhosis and positive intestinal bacteria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Shanshan, Wang, Qingqing, Wei, Fang, Zheng, Guoqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017475/ https://www.ncbi.nlm.nih.gov/pubmed/35449813 http://dx.doi.org/10.1155/2022/5063088

Ejemplares similares

Pingwei San Ameliorates Spleen Deficiency-Induced Diarrhea through Intestinal Barrier Protection and Gut Microbiota Modulation
por: Fan, Yimeng, et al.
Publicado: (2023)

Effect of Compound Lactic Acid Bacteria Capsules on the Small Intestinal Bacterial Overgrowth in Patients with Depression and Diabetes: A Blinded Randomized Controlled Clinical Trial
por: Wei, Fang, et al.
Publicado: (2022)

Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Xianglian Pill Suppresses Inflammation and Protects Intestinal Epithelial Barrier by Promoting Autophagy in DSS Induced Ulcerative Colitis Mice
por: Wang, Bingyu, et al.
Publicado: (2021)

Retraction: Xianglian pill suppresses inflammation and protects intestinal epithelial barrier by promoting autophagy in DSS induced ulcerative colitis mice
Publicado: (2023)

The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis
por: Zhang, Yuying, et al.
Publicado: (2015)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

NMPA-approved traditional Chinese medicine-Pingwei Pill: new indication for colistin recovery against MCR-positive bacteria infection
por: Sheng, Qiushuang, et al.
Publicado: (2021)

Jiawei Xianglian Decoction (JWXLD), a Traditional Chinese Medicine (TCM), Alleviates CPT-11-Induced Diarrhea in Mice
por: Lu, Jinhua, et al.
Publicado: (2020)

Diet and intestinal bacterial overgrowth: Is there evidence?
por: Souza, Claudineia, et al.
Publicado: (2022)

Epidemiology of small intestinal bacterial overgrowth
por: Efremova, Irina, et al.
Publicado: (2023)

Co-delivery of metformin and levofloxacin hydrochloride using biodegradable thermosensitive hydrogel for the treatment of corneal neovascularization
por: Liu, Dong, et al.
Publicado: (2019)

Comparison of the Gut Microbiota Between Pulsatilla Decoction and Levofloxacin Hydrochloride Therapy on Escherichia coli Infection
por: Liu, Xiaoye, et al.
Publicado: (2020)

Carboxylated cellulose nanofiber/montmorillonite nanocomposite for the removal of levofloxacin hydrochloride antibiotic from aqueous solutions
por: Li, Junfeng, et al.
Publicado: (2020)

Pulmonary Targeting of Levofloxacin Using Microsphere-Based Dry Powder Inhalation
por: Al Hagbani, Turki, et al.
Publicado: (2022)

Small Intestinal Bacterial Overgrowths and Intestinal Methanogen Overgrowths Breath Testing in a Real-Life French Cohort
por: Plauzolles, Anne, et al.
Publicado: (2022)

Xianglian Zhixie Tablet Antagonizes Dextran Sulfate Sodium-Induced Ulcerative Colitis by Attenuating Systemic Inflammation and Modulating Gut Microbiota
por: Li, Yilin, et al.
Publicado: (2023)

Cellulose nanocrystals/graphene oxide composite for the adsorption and removal of levofloxacin hydrochloride antibiotic from aqueous solution
por: Tao, Junhong, et al.
Publicado: (2020)

Small intestinal bacterial overgrowth syndrome in children
por: Siniewicz-Luzeńczyk, Katarzyna, et al.
Publicado: (2015)

Small intestinal bacterial overgrowth in Alzheimer’s disease
por: Kowalski, Karol, et al.
Publicado: (2021)

In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa
por: Chachanidze, Vladimir, et al.
Publicado: (2009)

Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori
por: Yun, Sang-Pil, et al.
Publicado: (2012)

Study on the mechanism of action of effective monomeric, berberine of Xianglian Pill in inhibiting human colon cancer cells based on fatty acid synthase target
por: Li, Shi-ying, et al.
Publicado: (2023)

Trihexyphenidyl hydrochloride: a powder diffraction study
por: Maccaroni, Elisabetta, et al.
Publicado: (2010)

Levofloxacin is phytotoxic and modifies the protein profile of lupin seedlings
por: Orzoł, Aleksandra, et al.
Publicado: (2017)

The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2020)

Link between hypothyroidism and small intestinal bacterial overgrowth
por: Patil, Anant D.
Publicado: (2014)

The duodenal microbiome is altered in small intestinal bacterial overgrowth
por: Leite, Gabriela, et al.
Publicado: (2020)

How to Recognize and Treat Small Intestinal Bacterial Overgrowth?
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2022)

Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics
por: Revaiah, Pruthvi C, et al.
Publicado: (2018)

Small Intestinal Bacterial Overgrowth is Associated with Intestinal Inflammation in the Irritable Bowel Syndrome
por: DAVID, LILIANA, et al.
Publicado: (2014)

Small intestinal bacterial overgrowth in children with intestinal failure on home parenteral nutrition
por: McGrath, Kathleen H, et al.
Publicado: (2019)

Interim Study: Comparison Of Safety And Efficacy of Levofloxacin Plus Colistin Regimen With Levofloxacin Plus High Dose Ampicillin/Sulbactam Infusion In Treatment of Ventilator-Associated Pneumonia Due To Multi Drug Resistant Acinetobacter
por: Mosaed, Reza, et al.
Publicado: (2018)

Gastrointestinal complaints in runners are not due to small intestinal bacterial overgrowth
por: Schommer, Kai, et al.
Publicado: (2011)

Small Intestine Bacterial Overgrowth and Environmental Enteropathy in Bangladeshi Children
por: Donowitz, Jeffrey R., et al.
Publicado: (2016)

Role of Small Intestinal Bacterial Overgrowth in Functional Gastrointestinal Disorders
por: Choi, Chang Hwan, et al.
Publicado: (2016)

Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
por: Augustyn, Monika, et al.
Publicado: (2019)

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update
por: Takakura, Will, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t35g2g52n5l30m4k5e7uflbtkh